Overview

Benralizumab Effect on Severe Chronic Rhinosinusitis With Eosinophilic Polyposis

Status:
Completed
Trial end date:
2020-02-01
Target enrollment:
Participant gender:
Summary
Benralizumab will be used in a placebo controlled randomized study to treat severe chronic rhinosinusitis with nasal polyps
Phase:
Phase 2
Details
Lead Sponsor:
Johns Hopkins University
Treatments:
Benralizumab